Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/661189


Brazil Joint Reconstruction and Orthobiologics Investment Opportunities, Analysis and Forecasts to 2012


Description: This report is an essential source for in-depth information and data relating to Brazil joint reconstruction and orthobiologics market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information and latest news, financial deals and pipeline products information of each of the key segments and sub-segments of the joint reconstruction and orthobiologics in Brazil

Scope

-The report provides Brazil joint reconstruction and orthobiologics information broken down into detailed segments and sub-segments.

-Total revenues, products sold, end users, and average pricing.

-Market shares of all the key competitors.

-Key pipeline products that are set to shape the market, broken down by sector.

-Information on the companies in the joint reconstruction and orthobiologics market in Brazil covering business description, strategic analysis and pipeline products.

-Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.

-Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.

-Key mergers and acquisitions, partnerships, private equity investments and IPOs.
Customer, hospitals and physicians data.


Reasons to buy

-Gain a strong understanding of the joint reconstruction and orthobiologics market in Brazil.

-Evaluate and compare the attractiveness of the market in country.

-Identify growth segments and opportunities in each industry sector in country.

-Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in country.

-Analyze the competitiveness of the market in the region and identify hotspots.

-Develop strategies based on the latest product, brand, expansion and research and development news in country.

-Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in country.

-Identify and analyze the strengths and weaknesses of the industry incumbents.


Contents: 1 Contents 2
1.1 List of Tables 8
1.2 List of Figures 10

2 Introduction 12

3 Definitions of Markets Covered in the Report 13
3.1 Joint Reconstruction 13
3.1.1 Ankle Replacement 13
3.1.2 Digits Replacement 13
3.1.3 Elbow Replacement 13
3.1.4 Hip Replacement 13
3.1.4.1 Partial Hip Replacement 13
3.1.4.2 Primary Hip Replacement 13
3.1.4.3 Revision Hip Replacement 14
3.1.5 Knee Replacement 14
3.1.5.1 Partial Knee Replacement 14
3.1.5.2 Primary Knee Replacement 14
3.1.5.3 Revision Knee Replacement 14
3.1.6 Shoulder Replacement 14
3.1.6.1 Partial Shoulder Replacement 14
3.1.6.2 Primary Shoulder Replacement 14
3.1.6.3 Revision Shoulder Replacement 15
3.1.7 Wrist Replacement 15
3.2 Orthobiologics 15
3.2.1 Bone Allografts 15
3.2.2 Bone Graft Substitutes 15
3.2.2.1 Bone Morphogentic Proteins (BMP) 15
3.2.2.2 Synthetic Bone Graft Substitutes 15
3.2.3 Bone Growth and Spinal Stimulation 15
3.2.4 Viscosupplementation 16

4 Healthcare Sector Review 17
4.1 Healthcare Expenditure 17
4.2 Healthcare Infrastructure 18
4.3 Healthcare Policy 18

5 Regulation System 19
5.1 Medical Device Registration Protocol 19
5.1.1 Registration Documentation 19
5.1.2 Registration Procedure 20
5.1.3 Medical Device Registration Fee 21

6 Pricing and Reimbursement 22

7 Distribution Structure 23

8 Brazil Joint Reconstruction and Orthobiologics Market Dynamics 24
8.1 Market Drivers 24
8.2 Market Restraints 25

9 Joint Reconstruction and Orthobiologics in Brazil 26
9.1 Joint Reconstruction and Orthobiologics Overall Revenues (2000-2012) 26
9.2 Joint Reconstruction and Orthobiologics Overall Volume (2000-2012) 29
9.3 Joint Reconstruction and Orthobiologics Overall Company Share (2006-2007) 32

10 Joint Reconstruction in Brazil 33
10.1 Joint Reconstruction Revenues by Segment (2000-2012) 33
10.1.1 Hip Replacement Revenues by Sub-Segment (2000-2012) 37
10.1.2 Knee Replacement Revenues by Sub-Segment (2000-2012) 39
10.1.3 Shoulder Replacement Revenues by Sub-Segment (2000-2012) 41
10.2 Joint Reconstruction Volume by Segment (2000-2012) 43
10.2.1 Hip Replacement Volume by Sub-Segment (2000-2012) 47
10.2.2 Knee Replacement Volume by Sub-Segment (2000-2012) 49
10.2.3 Shoulder Replacement Volume by Sub-Segment (2000-2012) 51
10.3 Joint Reconstruction Average Price (2000-2012) 53
10.4 Joint Reconstruction Distribution Share (2006-2007) 55
10.5 Joint Reconstruction Company Share (2006-2007) 56

11 Orthobiologics in Brazil 57
11.1 Orthobiologics Revenues by Segment (2000-2012) 57
11.1.1 Bone Graft Substitutes Revenues by Sub-Segment (2000-2012) 60
11.2 Orthobiologics Volume by Segment (2000-2012) 62
11.2.1 Bone Graft Substitutes Volume by Sub-Segment (2000-2012) 64
11.3 Orthobiologics Average Price (2000-2012) 66
11.4 Orthobiologics Distribution Share (2006-2007) 67
11.5 Orthobiologics Company Share (2006-2007) 68

12 Zimmer Holdings, Inc. Company Profile 69
12.1 Company Overview 69
12.2 Value Chain Analysis 70
12.2.1 Manufacturing 70
12.2.1.1 In House Manufacturing 70
12.2.2 Product Development 70
12.2.2.1 Regulatory Approvals 70
12.2.2.2 Clinical Trials 71
12.2.2.3 Research and Development 71
12.2.3 Sales and Marketing 71
12.2.3.1 Partnerships and Alliances 71
12.2.3.2 Licensing Agreements 71
12.3 Zimmer Holdings, Inc. Pipeline Products 72
12.3.1 Zimmer Holdings, Inc. Pipeline Products by Equipment Type 72
12.3.2 Zimmer Holdings, Inc. Pipeline Products by Development Stage 72
12.3.3 Zimmer Holdings, Inc. Pipeline Products by Therapy Area 72
12.3.4 Zimmer Holdings, Inc. Pipeline Products by Clinical Trials 73
12.3.5 Zimmer Holdings, Inc. Pipeline Products by News Summary 73

13 Synthes GmbH Company Profile 74
13.1 Company Overview 74
13.2 Value Chain Analysis 75
13.2.1 Manufacturing 75
13.2.1.1 In House Manufacturing 75
13.2.2 Product Development 75
13.2.2.1 Clinical Trials 75
13.2.2.2 Regulatory Approvals 76
13.2.2.3 Research and Development 76
13.2.3 Sales and Marketing 76
13.2.3.1 Partnerships and Alliances 76
13.3 Synthes GmbH Pipeline Products 77
13.3.1 Synthes GmbH Pipeline Products by Equipment Type 77
13.3.2 Synthes GmbH Pipeline Products by Development Stage 77
13.3.3 Synthes GmbH Pipeline Products by Therapy Area 77
13.3.4 Synthes GmbH Pipeline Products by Clinical Trials 77

14 Biomet, Inc. Company Profile 78
14.1 Company Overview 78
14.2 Value Chain Analysis 78
14.2.1 Manufacturing 79
14.2.1.1 In House Manufacturing 79
14.2.2 Product Development 79
14.2.2.1 Regulatory Approvals 79
14.2.2.2 Research and Development 79
14.2.2.3 Clinical Trials 80
14.2.3 Sales and Marketing 80
14.2.3.1 Partnerships and Alliances 80
14.2.3.2 Licensing Agreements 80
14.3 Biomet, Inc. Pipeline Products 81
14.3.1 Biomet, Inc. Pipeline Products by Equipment Type 81
14.3.2 Biomet, Inc. Pipeline Products by Development Stage 82
14.3.3 Biomet, Inc. Pipeline Products by Therapy Area 83
14.3.4 Biomet, Inc. Pipeline Products By Clinical Trials 83

15 DePuy, Inc. Company Profile 84
15.1 Company Overview 84
15.2 DePuy, Inc. Pipeline Products 84
15.2.1 DePuy, Inc. Pipeline Products by Equipment Type 84
15.2.2 DePuy, Inc. Pipeline Products by Development Stage 84
15.2.3 DePuy, Inc. Pipeline Products by Therapy Area 85
15.2.4 DePuy, Inc. Pipeline Products by Clinical Trials 85
15.2.5 DePuy, Inc. Pipeline Products by News Summary 85

16 Stryker Corporation Company Profile 86
16.1 Company Overview 86
16.2 Value Chain Analysis 86
16.2.1 Manufacturing 87
16.2.1.1 In House Manufacturing 87
16.2.2 Product Development 87
16.2.2.1 Clinical Trials 87
16.2.2.2 Research and Development 87
16.2.2.3 Regulatory Approvals 88
16.2.3 Sales and Marketing 88
16.2.3.1 Partnerships and Alliances 88
16.3 Stryker Corporation Pipeline Products 88
16.3.1 Stryker Corporation Pipeline Products by Equipment Type 88
16.3.2 Stryker Corporation Pipeline Products by Development Stage 89
16.3.3 Stryker Corporation Pipeline Products by Therapy Area 89
16.3.4 Stryker Corporation Pipeline Products by Clinical Trials 89
16.3.5 Stryker Corporation Pipeline Products By News Summary 90

17 Medtronic, Inc. Company Profile 91
17.1 Company Overview 91
17.2 Value Chain Analysis 91
17.2.1 Manufacturing 92
17.2.1.1 In House Manufacturing 92
17.2.2 Product Development 92
17.2.2.1 Regulatory Approvals 92
17.2.2.2 Research and Development 92
17.2.2.3 Clinical Trials 92
17.2.3 Sales and Marketing 92
17.2.3.1 Licensing Agreements 93
17.2.3.2 Partnerships and Alliances 93
17.3 Medtronic, Inc. Pipeline Products 93
17.3.1 Medtronic, Inc. Pipeline Products by Equipment Type 93
17.3.2 Medtronic, Inc. Pipeline Products by Development Stage 94
17.3.3 Medtronic, Inc. Pipeline Products by Therapy Area 96
17.3.4 Medtronic, Inc. Pipeline Products by Clinical Trials 97
17.3.5 Medtronic, Inc. Pipeline Products by News Summary 98

18 Baumer S.A. Company Profile 99
18.1 Company Overview 99

19 Impol Instrumental e Implantes Ltda Company Profile 100
19.1 Company Overview 100

20 Appendix 101
20.1 Research Methodology 101
20.2 Coverage 102
20.3 Secondary Research 102
20.4 Primary Research 103
20.5 Models 103
20.6 Forecasts 104
20.7 Expert Panels 104
20.8 Currency Conversion 105
20.9 Contact Us 106
20.10 Disclaimer 106

1.1 List of Tables
Table 1: Medical Device Registration Fee in Brazil, 2002 21
Table 2: Joint Reconstruction and Orthobiologics, Brazil, Overall Revenues ($ mn), 2000-2012 26
Table 3: Joint Reconstruction and Orthobiologics, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 27
Table 4: Joint Reconstruction and Orthobiologics, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 28
Table 5: Joint Reconstruction and Orthobiologics, Brazil, Overall Volume (Units), 2000-2012 29
Table 6: Joint Reconstruction and Orthobiologics, Brazil, Overall Volume (Units), Historic, 2000-2007 30
Table 7: Joint Reconstruction and Orthobiologics, Brazil, Overall Volume (Units), Forecast, 2007-2012 31
Table 8: Joint Reconstruction and Orthobiologics, Brazil, Company Share by Revenue ($ mn), 2006-20067 32
Table 9: Joint Reconstruction, Brazil, Portfolio Analysis 34
Table 10: Joint Reconstruction, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2007 35
Table 11: Joint Reconstruction, Brazil, Revenue ($ mn) by Segment, Forecast, 2007-2012 36
Table 12: Hip Replacement, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2007 37
Table 13: Hip Replacement, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2007-2012 38
Table 14: Knee Replacement, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2007 39
Table 15: Knee Replacement, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2007-2012 40
Table 16: Shoulder Replacement, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2007 41
Table 17: Shoulder Replacement, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2007-2012 42
Table 18: Joint Reconstruction, Brazil, Volume (Units) by Segment, Historic, 2000-2007 44
Table 19: Joint Reconstruction, Brazil, Volume (Units) by Segment, Forecast, 2007-2012 46
Table 20: Hip Replacement, Brazil, Volume (Units) by Sub-Segment, Historic, 2000-2007 47
Table 21: Hip Replacement, Brazil, Volume (Units) by Sub-Segment, Forecast, 2007-2012 48
Table 22: Knee Replacement, Brazil, Volume (Units) by Sub-Segment, Historic, 2000-2007 49
Table 23: Knee Replacement, Brazil, Volume (Units) by Sub-Segment, Forecast, 2007-2012 50
Table 24: Shoulder Replacement, Brazil, Volume (Units) by Sub-Segment, Historic, 2000-2007 51
Table 25: Shoulder Replacement, Brazil, Volume (Units) by Sub-Segment, Forecast, 2007-2012 52
Table 26: Joint Reconstruction, Brazil, Average Price ($), Historic, 2000-2007 53
Table 27: Joint Reconstruction, Brazil, Average Price ($), Forecast, 2007-2012 54
Table 28: Joint Reconstruction, Brazil, Distribution Share by Revenue ($ mn), 2006-2007 55
Table 29: Joint Reconstruction, Brazil, Company Share by Revenue ($ mn), 2006-20067 56
Table 30: Orthobiologics, Brazil, Market Portfolio Analysis 57
Table 31: Orthobiologics, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2007 58
Table 32: Orthobiologics, Brazil, Revenue ($ mn) by Segment, Forecast, 2007-2012 59
Table 33: Bone Graft Substitutes, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2007 60
Table 34: Bone Graft Substitutes, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2007-2012 61
Table 35: Orthobiologics, Brazil, Volume (Units) by Segment, Historic, 2000-2007 62
Table 36: Orthobiologics, Brazil, Volume (Units) by Segment, Forecast, 2007-2012 63
Table 37: Bone Graft Substitutes, Brazil, Volume (Units) by Sub-Segment, Historic, 2000-2007 64
Table 38: Bone Graft Substitutes, Brazil, Volume (Units) by Sub-Segment, Forecast, 2007-2012 65
Table 39: Orthobiologics, Brazil, Average Price ($), Historic, 2000-2007 66
Table 40: Orthobiologics, Brazil, Average Price ($), Forecast, 2007-2012 66
Table 41: Orthobiologics, Brazil, Distribution Share by Revenue ($ mn), 2006-2007 67
Table 42: Orthobiologics, Brazil, Company Share by Revenue ($ mn), 2006-2007 68
Table 43: Zimmer Holdings, Inc. Pipeline Products by Equipment Type 72
Table 44: Zimmer Holdings, Inc. Pipeline Products by Development Stage 72
Table 45: Zimmer Holdings, Inc. Pipeline Products by Therapy Area 72
Table 46: Zimmer Holdings, Inc. Pipeline Products by Clinical Trials 73
Table 47: Zimmer Holdings, Inc. Pipeline Products by News Summaries 73
Table 48: Synthes GmbH Pipeline Products by Equipment Type 77
Table 49: Synthes GmbH Pipeline Products by Development Stage 77
Table 50: Synthes GmbH Pipeline Products by Therapy Area 77
Table 51: Synthes GmbH Pipeline Products by Clinical Trials 77
Table 52: Biomet, Inc. Pipeline Products by Equipment Type 81
Table 53: Biomet, Inc. Pipeline Products by Development Stage 82
Table 54: Biomet, Inc. Pipeline Products by Therapy Area 83
Table 55: Biomet, Inc. Pipeline Products By Clinical Trials 83
Table 56: DePuy, Inc. Pipeline Products by Equipment Type 84
Table 57: DePuy, Inc. Pipeline Products by Development Stage 84
Table 58: DePuy, Inc. Pipeline Products by Therapy Area 85
Table 59: DePuy, Inc. Pipeline Products by Clinical Trials 85
Table 60: DePuy, Inc. Pipeline Products by News Summaries 85
Table 61: Stryker Corporation Pipeline Products by Equipment Type 88
Table 62: Stryker Corporation Pipeline Products by Development Stage 89
Table 63: Stryker Corporation Pipeline Products by Therapy Area 89
Table 64: Stryker Corporation Pipeline Products by Clinical Trials 89
Table 65: Stryker Corporation Pipeline Products By News Summaries 90
Table 66: Medtronic, Inc. Pipeline Products by Equipment Type 93
Table 67: Medtronic, Inc. Pipeline Products by Development Stage 94
Table 68: Medtronic, Inc. Pipeline Products by Therapy Area 96
Table 69: Medtronic, Inc. Pipeline Products by Clinical Trials 97
Table 70: Medtronic, Inc. Pipeline Products by News Summaries 98
Table 71: Currency Conversion from USD to Local Currency at 2007 Constant Rate 105

1.2 List of Figures
Figure 1: Health Expenditure by Source in Brazil, 2006 18
Figure 2: Joint Reconstruction and Orthobiologics, Brazil, Overall Revenues($ mn), 2000-2012 26
Figure 3: Joint Reconstruction and Orthobiologics, Brazil, Overall Revenues($ mn), Historic, 2000-2007 27
Figure 4: Joint Reconstruction and Orthobiologics, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 28
Figure 5: Joint Reconstruction and Orthobiologics, Brazil, Overall Volume (Units), 2000-2012 29
Figure 6: Joint Reconstruction and Orthobiologics, Brazil, Overall Volume (Units), Historic, 2000-2007 30
Figure 7: Joint Reconstruction and Orthobiologics, Brazil, Overall Volume (Units), Forecast, 2007-2012 31
Figure 8: Joint Reconstruction and Orthobiologics, Brazil, Company Share (%), 2007 32
Figure 9: Joint Reconstruction, Brazil, Portfolio Analysis, 2007 33
Figure 10: Joint Reconstruction, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2007 35
Figure 11: Joint Reconstruction, Brazil, Revenue ($ mn) by Segment, Forecast, 2007-2012 36
Figure 12: Hip Replacement, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2007 37
Figure 13: Hip Replacement, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2007-2012 38
Figure 14: Knee Replacement, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2007 39
Figure 15: Knee Replacement, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2007-2012 40
Figure 16: Shoulder Replacement, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2007 41
Figure 17: Shoulder Replacement, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2007-2012 42
Figure 18: Joint Reconstruction, Brazil, Volume (Units) by Segment, Historic, 2000-2007 43
Figure 19: Joint Reconstruction, Brazil, Volume (Units) by Segment, Forecast, 2007-2012 45
Figure 20: Hip Replacement, Brazil, Volume (Units) by Sub-Segment, Historic, 2000-2007 47
Figure 21: Hip Replacement, Brazil, Volume (Units) by Sub-Segment, Forecast, 2007-2012 48
Figure 22: Knee Replacement, Brazil, Volume (Units) by Sub-Segment, Historic, 2000-2007 49
Figure 23: Knee Replacement, Brazil, Volume (Units) by Sub-Segment, Forecast, 2007-2012 50
Figure 24: Shoulder Replacement, Brazil, Volume (Units) by Sub-Segment, Historic, 2000-2007 51
Figure 25: Shoulder Replacement, Brazil, Volume (Units) by Sub-Segment, Forecast, 2007-2012 52
Figure 26: Joint Reconstruction, Brazil, Company Share (%), 2007 56
Figure 27: Orthobiologics, Brazil, Market Portfolio Analysis, 2007 57
Figure 28: Orthobiologics, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2007 58
Figure 29: Orthobiologics, Brazil, Revenue ($ mn) by Segment, Forecast, 2007-2012 59
Figure 30: Bone Graft Substitutes, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2007 60
Figure 31: Bone Graft Substitutes, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2007-2012 61
Figure 32: Orthobiologics, Brazil, Volume (Units) by Segment, Historic, 2000-2007 62
Figure 33: Orthobiologics, Brazil, Volume (Units) by Segment, Forecast, 2007-2012 63
Figure 34: Bone Graft Substitutes, Brazil, Volume (Units) by Sub-Segment, Historic, 2000-2007 64
Figure 35: Bone Graft Substitutes, Brazil, Volume (Units) by Sub-Segment, Forecast, 2007-2012 65
Figure 36: Orthobiologics, Brazil, Company Share (%), 2007 68
Figure 37: Zimmer Holdings, Inc. Value Chain Analysis 70
Figure 38: Synthes GmbH Value Chain Analysis 75
Figure 39: Biomet, Inc. Value Chain Analysis 78
Figure 40: Stryker Corporation Value Chain Analysis 86
Figure 41: Medtronic, Inc. Value Chain Analysis 91
Figure 42: Methodology 101


Companies Mentioned Zimmer Holdings, Inc. Synthes GmbH Biomet, Inc. DePuy, Inc. Stryker Corporation Medtronic, Inc. Baumer S.A. Impol Instrumental e Implantes Ltda


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/661189

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 26/11/2009 06:08:13
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Brazil Joint Reconstruction and Orthobiologics Investment Opportunities, Analysis and Forecasts to 2012
Web Address:
http://www.researchandmarkets.com/reports/661189
Office Code:
OC8HJNMPMSTQQ

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €3,358.00
Electronic (PDF) - Site License €6,716.00
Electronic (PDF) - Enterprisewide €10,074.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 26/11/2009 06:08:13

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)